Thomas Kissel

Active 1991–2020

121
Papers
24,584
Citations
96
h-index
121
i10-index

Citations

Citations per year for Thomas Kissel1992: 2 citations1993: 9 citations1994: 8 citations1995: 18 citations1996: 25 citations1997: 21 citations1998: 47 citations1999: 44 citations2000: 59 citations2001: 66 citations2002: 77 citations2003: 138 citations2004: 179 citations2005: 237 citations2006: 284 citations2007: 312 citations2008: 366 citations2009: 398 citations2010: 393 citations2011: 419 citations2012: 331 citations2013: 288 citations2014: 297 citations2015: 264 citations2016: 232 citations2017: 164 citations2018: 159 citations2019: 504 citations2020: 456 citations2021: 460 citations2022: 312 citations2023: 217 citations2024: 298 citations2025: 136 citations2026: 3 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,430 citing papers, 19.8% of this breakdownChina: 1,035 citing papers, 14.3% of this breakdownGermany: 502 citing papers, 7% of this breakdownIndia: 403 citing papers, 5.6% of this breakdownUnited Kingdom: 296 citing papers, 4.1% of this breakdownSouth Korea: 285 citing papers, 3.9% of this breakdownFrance: 193 citing papers, 2.7% of this breakdownCanada: 188 citing papers, 2.6% of this breakdownJapan: 177 citing papers, 2.5% of this breakdownIran: 175 citing papers, 2.4% of this breakdownItaly: 167 citing papers, 2.3% of this breakdownSpain: 164 citing papers, 2.3% of this breakdown
0%19.8%Other 30.5%

Fields

  • Biochemistry, Genetics and Molecular Biology36.1%
  • Materials Science20.7%
  • Pharmacology, Toxicology and Pharmaceutics15.9%
  • Medicine14.3%
  • Engineering4.6%
  • Immunology and Microbiology2.8%
  • Other5.6%

Topics

  • RNA Interference and Gene Delivery13.6%
  • Advanced Drug Delivery Systems8.9%
  • Advanced biosensing and bioanalysis techniques8.1%
  • Nanoparticle-Based Drug Delivery7.1%
  • Virus-based gene therapy research3%
  • Drug Solubulity and Delivery Systems2.9%
  • Other56.4%

Coauthors

All papers

Open in search
  1. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis

    Authors: , , , , - Biomaterials 2003 cited by 2,303

  2. Chitosan-based formulations for delivery of DNA and siRNA

    Authors: , , - Advanced Drug Delivery Reviews 2009 cited by 953

  3. Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives

    Authors: , , - The Journal of Gene Medicine 2005 cited by 862

  4. Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection

    Authors: , , , , , , , , - Biomaterials 2010 cited by 527

  5. Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres

    Authors: , , , , , - International Journal of Pharmaceutics 2006 cited by 273

  6. Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features

    Authors: , , , , , , - Journal of Controlled Release 2002 cited by 177

  7. A Novel Non-Viral Vector for DNA Delivery Based on Low Molecular Weight, Branched Polyethylenimine: Effect of Molecular Weight on Transfection Efficiency and Cytotoxicity

    Authors: , , , , - Pharmaceutical Research 1999 cited by 1,208

  8. Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice

    Authors: , , , , , , - European Journal of Pharmaceutics and Biopharmaceutics 2003 cited by 446

  9. In situ forming parenteral drug delivery systems: an overview

    Authors: , , , - European Journal of Pharmaceutics and Biopharmaceutics 2004 cited by 409

  10. Biodegradable polymeric nanocarriers for pulmonary drug delivery

    Authors: , , , - Expert Opinion on Drug Delivery 2008 cited by 264

  11. Controlled pulmonary drug and gene delivery using polymeric nano-carriers

    Authors: , , - Journal of Controlled Release 2011 cited by 200

  12. Prospects for cationic polymers in gene and oligonucleotide therapy against cancer

    Authors: , , - Advanced Drug Delivery Reviews 2002 cited by 782

  13. Transport of Lipophilic Drug Molecules in a New Mucus-Secreting Cell Culture Model Based on HT29-MTX Cells

    Authors: , , , - Pharmaceutical Research 2001 cited by 219

  14. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method

    Authors: , , , , , - European Journal of Pharmaceutics and Biopharmaceutics 2007 cited by 162

  15. Biophysical investigation of pulmonary surfactant surface properties upon contact with polymeric nanoparticles in vitro

    Authors: , , , , , , , , - Nanomedicine Nanotechnology Biology and Medicine 2010 cited by 116

  16. Nonviral Pulmonary Delivery of siRNA

    Authors: , - Accounts of Chemical Research 2011 cited by 101

  17. Nonviral siRNA Delivery to the Lung: Investigation of PEG−PEI Polyplexes and Their In Vivo Performance

    Authors: , , , , , , , - Molecular Pharmaceutics 2009 cited by 187

  18. In vitro and in vivo complement activation and related anaphylactic effects associated with polyethylenimine and polyethylenimine-graft-poly(ethylene glycol) block copolymers

    Authors: , , , , , , , - Biomaterials 2011 cited by 133

  19. siRNA Delivery to the lung: What's new?

    Authors: , , - Advanced Drug Delivery Reviews 2014 cited by 132

  20. Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model

    Authors: , , , , , , , - International Journal of Pharmaceutics 2008 cited by 115

  21. Polymer-related off-target effects in non-viral siRNA delivery

    Authors: , , , , , , - Biomaterials 2010 cited by 104

  22. Iloprost-Containing Liposomes for Aerosol Application in Pulmonary Arterial Hypertension: Formulation Aspects and Stability

    Authors: , , , , , - Pharmaceutical Research 2006 cited by 83

  23. Characterization of commercially available and synthesized polyethylenimines for gene delivery

    Authors: , , , - Journal of Controlled Release 2000 cited by 510

  24. Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats

    Authors: , , - European Journal of Pharmaceutics and Biopharmaceutics 1998 cited by 352